CJC-1295 ( With DAC) | 2mg | 4 Pack | USA Made

Description

Product Overview

QuantaNova’s CJC-1295 with DAC is a high-purity, lyophilized research peptide offered in a 2 mg strength, bundled in a 4-vial pack. This long-acting GHRH analog is formulated with a proprietary freeze-drying process to protect integrity against temperature fluctuations during transit. Each batch is manufactured in-house for precise quality control and consistency. To ensure purity, potency, and safety, CJC-1295 with DAC is third-party tested by Vanguard Laboratory—an ISO-certified U.S. lab. PES micron filtration is utilized to remove contaminants and ensure sterility throughout the production process.

CJC-1295 with DAC Peptide Structure

• Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Gln-Ala-His-Gln-Gln-Trp-Leu-Asn-Asp-Ile-Ile-Trp-Gln-Leu-Arg-Lys-Lys-Gln-Gly-Gly-Gly-Gly-Cys
• Molecular Formula: C165H271N47O46
• Molecular Weight: 3649.01 g/mol
• CAS Number: 863288-34-0

Key Findings of CJC-1295 with DAC

• Promotes sustained release of growth hormone in animal models
• Studied for enhancing IGF-1 levels over extended periods
• Investigated for improved recovery and muscle regeneration in research subjects
• Examined for its long-acting plasma half-life due to DAC modification
• Explored in models involving fat metabolism and lean body composition

In-Depth Research Applications of CJC-1295 with DAC

Growth Hormone and IGF-1 Modulation

CJC-1295 with DAC has been heavily studied in preclinical models for its effect on endogenous growth hormone release. By mimicking GHRH (Growth Hormone-Releasing Hormone) and binding to albumin through its Drug Affinity Complex (DAC) component, the peptide achieves a significantly prolonged half-life. This allows for stable and elevated IGF-1 levels in vivo over time, making it useful in studies that examine growth factor regulation and hormonal cascades.

Research trials have demonstrated that a single administration of CJC-1295 with DAC can sustain elevated GH and IGF-1 levels for up to a week, reducing the need for frequent dosing in long-term studies. This pharmacokinetic advantage provides consistent stimulation of GH pulses without disrupting the natural feedback loop.

Neuroendocrine Regulation and Pituitary Signaling

Research involving CJC-1295 with DAC has examined its influence on the hypothalamic-pituitary axis. As a GHRH analog, it interacts directly with the anterior pituitary to stimulate GH secretion in a pulsatile pattern. Unlike shorter-acting analogs, the DAC-modified variant preserves this pulsatility while extending action duration, which is critical for hormonal homeostasis in research protocols.

Studies have explored the potential downstream effects on circadian rhythm regulation, sleep cycles, and overall neuroendocrine signaling. This makes CJC-1295 with DAC a focal point in laboratory models evaluating endocrine feedback and signaling pathways.

Muscle Regeneration and Tissue Repair

Animal studies have examined the effects of elevated GH and IGF-1 on muscle recovery, satellite cell activation, and tissue repair. CJC-1295 with DAC’s ability to support sustained hormonal release may facilitate improved outcomes in models focused on muscle regeneration, particularly in scenarios involving injury or age-related decline.

Some research has also suggested that consistent GH elevation may contribute to improved nitrogen retention and protein synthesis, potentially enhancing the cellular environment for muscle repair in research settings. These findings have prompted further interest in CJC-1295 with DAC as a model compound in musculoskeletal recovery protocols.

Fat Metabolism and Lean Body Composition

CJC-1295 with DAC has been explored in animal models for its potential to support fat metabolism and improve lean mass. By elevating GH and IGF-1 levels, this peptide may influence lipolysis pathways and energy utilization, contributing to favorable shifts in body composition.

Several studies have shown reductions in adipose tissue mass in GH-deficient models following peptide administration, alongside increases in muscle tissue. While early-stage, these findings continue to drive interest in how long-acting GHRH analogs like CJC-1295 with DAC may influence metabolic performance in lab-based research environments.

Resources

• Growth Hormone and IGF-1 Modulation
• Neuroendocrine Regulation and Pituitary Signaling
• Muscle Regeneration and Tissue Repair
• Fat Metabolism and Lean Body Composition

 

Usage & Storage Guidelines of CJC-1295 with DAC

• Handle using appropriate laboratory safety procedures.
• Storage (Lyophilized): Store at -20°C.
• After Reconstitution: Store between 2–8°C and use within 14–30 days.
• Diluent Recommendation: Reconstitute with bacteriostatic water or a suitable research-grade diluent.

Legal Disclaimer

This product is intended strictly for laboratory research purposes only. It is not a drug, food additive, cosmetic, or therapeutic substance, and must not be used in humans or animals. It is the buyer’s responsibility to handle the product safely and in accordance with applicable laws and regulations.